Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M109,182Revenue $M36,771Net Margin (%)11.5Altman Z-Score1.8
Enterprise Value $M120,009EPS $2.0Operating Margin %17.1Piotroski F-Score4
P/E(ttm)19.7Beneish M-Score-2.0Pre-tax Margin (%)15.8Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %2.3Quick Ratio0.9Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %-3.3Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow38.8y-y EBITDA Growth Rate %-47.9ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %4.0PEG--ROE % (ttm)9.1Less Shares Outstanding y-yN
Payout Ratio %79.0Shares Outstanding M2,622ROIC % (ttm)8.9Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYJames Barrow 2015-12-31 Add0.02%$41.51 - $51.49
($45.91)
$ 39.82-13%Add 1.26%29,489,368
SNYKen Fisher 2015-12-31 Add0.01%$41.51 - $51.49
($45.98)
$ 39.82-13%Add 0.90%13,416,220
SNYHOTCHKIS & WILEY 2015-09-30 Reduce-0.29%$46.64 - $54.98
($50.92)
$ 39.82-22%Reduce -15.57%9,035,695
SNYCharles Brandes 2015-09-30 Reduce-0.17%$46.64 - $54.98
($50.92)
$ 39.82-22%Reduce -10.56%2,290,031
SNYNWQ Managers 2015-09-30 Reduce-0.09%$46.64 - $54.98
($50.92)
$ 39.82-22%Reduce -5.10%2,501,826
SNYJames Barrow 2015-09-30 Reduce-0.06%$46.64 - $54.98
($50.92)
$ 39.82-22%Reduce -2.80%29,123,564
SNYKen Fisher 2015-09-30 Add0.01%$46.64 - $54.98
($50.92)
$ 39.82-22%Add 0.37%13,295,966
SNYDodge & Cox 2015-09-30 Add$46.64 - $54.98
($50.92)
$ 39.82-22%Add 0.19%49,859,813
SNYNWQ Managers 2015-06-30 Reduce-0.8%$48.81 - $52.35
($50.66)
$ 39.82-21%Reduce -32.87%2,636,361
SNYDodge & Cox 2015-06-30 Add0.3%$48.81 - $52.35
($50.66)
$ 39.82-21%Add 15.64%49,765,693
SNYHOTCHKIS & WILEY 2015-06-30 Reduce-0.19%$48.81 - $52.35
($50.66)
$ 39.82-21%Reduce -9.17%10,701,542
SNYJames Barrow 2015-06-30 Reduce-0.02%$48.81 - $52.35
($50.66)
$ 39.82-21%Reduce -0.87%29,961,207
SNYKen Fisher 2015-06-30 Add0.02%$48.81 - $52.35
($50.66)
$ 39.82-21%Add 1.44%13,246,593
SNYCharles Brandes 2015-06-30 Reduce-0.01%$48.81 - $52.35
($50.66)
$ 39.82-21%Reduce -0.52%2,560,460
SNYNWQ Managers 2015-03-31 Add0.61%$44 - $51.12
($47.81)
$ 39.82-17%Add 33.50%3,927,517
SNYJames Barrow 2015-03-31 Reduce-0.04%$44 - $51.12
($47.81)
$ 39.82-17%Reduce -1.88%30,225,221
SNYHOTCHKIS & WILEY 2015-03-31 Add0.02%$44 - $51.12
($47.81)
$ 39.82-17%Add 0.77%11,782,180
SNYThird Avenue Management 2015-03-31 Sold Out -0.012%$44 - $51.12
($47.81)
$ 39.82-17%Sold Out0
SNYDodge & Cox 2015-03-31 Reduce-0.01%$44 - $51.12
($47.81)
$ 39.82-17%Reduce -0.55%43,034,073
SNYFirst Eagle Investment 2015-03-31 Sold Out -0.0038%$44 - $51.12
($47.81)
$ 39.82-17%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-58.08view
Sanofi10% Owner 2015-01-26Buy647,448$95-58.08view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-57.26view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-40.46view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67419.17view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Dodge & Cox Global Stock Fund 4th Quarter Commentary Jan 19 2016 
    Dodge & Cox Stock Fund 2015 Commentary Jan 18 2016 
    Why MannKind Could Be a Value Trap Jan 04 2016 
    Francis Chou's Holdings Trading at Low PE Dec 23 2015 
    Warren Buffett Further Pares Munich Re Stake Dec 14 2015 
    Weekly 3-Year Low Highlights: Sanofi, Exelon, Cummins, W.W. Grainger Nov 18 2015 
    Why Warren Buffett Sold Munich Re Oct 06 2015 
    MS Global Franchise Fund Reduces Positions in Sanofi, Diageo Sep 16 2015 
    Third Avenue International Value Fund Part 2 Sep 10 2015 
    Dodge & Cox Funds' 2015 Equity Mid-Year Review Aug 19 2015 

    More From Other Websites
    Trade Boost From Trans-Pacific Partnership? Feb 06 2016
    Drug Manufacturers - Major Equities Technical Updates -- TherapeuticsMD, Sanofi, Shire, and Novartis Feb 04 2016
    Sanofi Begins Search for Vaccine for Zika Virus as Fear Grows Feb 03 2016
    First U.S. Zika virus transmission reported, attributed to sex Feb 03 2016
    First U.S. Zika virus transmission reported, attributed to sex Feb 03 2016
    Moderate Improvements in Blood Glucose Levels Could Deliver Significant Benefits for People With... Feb 03 2016
    [$$] Drug Industry Starts Race to Develop Zika Vaccine Feb 03 2016
    The Latest: Chile reports its first 3 confirmed Zika cases Feb 02 2016
    The Latest: Chile reports its first 3 confirmed Zika cases Feb 02 2016
    First U.S. Zika virus transmission reported, sexual transmission cited Feb 02 2016
    Cambridge developer of cystic fibrosis drugs joins choppy IPO waters Feb 02 2016
    Quest for Zika vaccine widens; Africa, Asia deemed vulnerable Feb 02 2016
    Video-Q3 2015 RESULTS for Sanofi Feb 02 2016
    Merck, Sanofi Exploring Potential End To Joint Venture In Europe Feb 02 2016
    [$$] Sanofi to Launch Zika Vaccine Research Feb 02 2016
    Sanofi plans 600 job cuts in France over 3 years Feb 02 2016
    Drugmaker Sanofi Pasteur launches effort for Zika vaccine Feb 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK